Liran Belenzon ^UDM

Liran Belenzon, CEO at BenchSci, plays a critical role in revolutionizing pharmaceutical research with AI. BenchSci's machine learning platform enhances the speed and quality of research by optimizing reagent procurement and experiment success. Under Liran's leadership, BenchSci now serves 15 of the top 20 pharmaceutical companies and over 3,600 academic centers globally.